Stocks
Capricor Therapeutics, Inc.CAPR
NASDAQHealthcareBiotechnology$30.50-8.74%
Price as of · delayed, not real-time
Focused on developing transformative cell and exosome-based therapeutics, this biotech firm specializes in treatments for rare diseases and regenerative medicine. Investors monitor its clinical-stage pipeline, particularly for Duchenne muscular dystrophy and cardiac conditions, given its partnerships with major pharmaceutical companies.
Market Cap: $1.4B52W Range: $4.30 – $40.37
Congressional Interest in Capricor Therapeutics, Inc. (CAPR)
1 member of Congress has disclosed 2 trades in Capricor Therapeutics, Inc. (CAPR), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 1 sale. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
1
Buys
1
Sells
1
Who in Congress Is Trading CAPR?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-07-27 | Roger W. Marshall | sell | $1K – $15K |
| 2017-07-27 | Roger W. Marshall | buy | $1K – $15K |